General MedicationsORALGeneric
PHOSLO
CALCIUM ACETATE
Standard Dose
333.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PHOSLO is listed in Drugs@FDA under application 021160 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM ACETATE Form and strength CAPSULE;ORAL - 333.5MG Sponsor FRESENIUS MEDCL CARE Submission history Latest submission status date: 2016-06-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHOSLO is listed in Drugs@FDA under application 021160 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM ACETATE Form and strength CAPSULE;ORAL - 333.5MG Sponsor FRESENIUS MEDCL CARE Submission history Latest submission status date: 2016-06-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.